Search clinical trials for: Nivolumab Ipilimumab
Total 1957 results
-
Melanoma Institute AustraliaBristol-Myers SquibbRecruitingMelanoma Stage IvAustralia, Norway
-
NYU Langone HealthBristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Herlev HospitalTerminated
-
Gustave Roussy, Cancer Campus, Grand ParisWithdrawnColorectal Cancer MetastaticFrance
-
UNC Lineberger Comprehensive Cancer CenterBristol-Myers Squibb; AmgenActive, not recruitingColon CancerUnited States
-
Herlev HospitalBristol-Myers SquibbCompletedMetastatic Pancreatic Cancer | Metastatic Biliary Tract CancerDenmark
-
SQZ BiotechnologiesCompletedStudy of SQZ-PBMC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid TumorsAdult Solid TumorUnited States, Canada, Germany
-
National Cancer Institute (NCI)WithdrawnHematopoietic and Lymphoid Cell Neoplasm | Lynch Syndrome | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Neuroblastoma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary Central... and other conditionsUnited States, Canada
-
University of Texas Southwestern Medical CenterBristol-Myers Squibb; Boston Scientific Corporation; American Society of Clinical... and other collaboratorsRecruitingBreast CancerUnited States
-
Bristol-Myers SquibbYale UniversityCompletedNon-Small Cell Lung CancerBelgium, Italy, United States, France, Germany, Netherlands, Spain, Romania
-
Johannes Laengle, MD, PhDBristol-Myers SquibbCompleted
-
Hackensack Meridian HealthTerminatedAcute Myeloid Leukemia and Myelodysplastic SyndromeUnited States
-
University of ChicagoCompletedMesothelioma | Peritoneal MesotheliomaUnited States
-
Idera Pharmaceuticals, Inc.Bristol-Myers SquibbActive, not recruiting
-
AbbVieBristol-Myers SquibbTerminatedSmall Cell Lung CancerUnited States, France, Germany, Italy, Spain
-
Inna Chen, MDRecruiting
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Advanced MelanomaUnited States, Netherlands, Spain
-
University of ChicagoActive, not recruitingStage IV Small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedMetastatic Melanoma | Unresectable MelanomaUnited States, France
-
Georgetown UniversityBristol-Myers Squibb; M.D. Anderson Cancer Center; University of Colorado, Denver and other collaboratorsTerminatedMucosal Melanoma | Acral Lentiginous MelanomaUnited States
-
Dana-Farber Cancer InstituteBristol-Myers SquibbActive, not recruitingHead and Neck CancerUnited States
-
Melanoma Institute AustraliaBristol-Myers Squibb; Melanoma and Skin Cancer Trials LimitedActive, not recruitingMelanoma | Brain MetastasesAustralia
-
Salma SabbourBristol-Myers Squibb; Rutgers Cancer Institute of New Jersey; BeyondSpring Pharmaceuticals...Active, not recruitingLung Cancer | SCLCUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Mayo ClinicActive, not recruitingMetastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Clinical Stage IV Cutaneous Melanoma AJCC v8United States
-
The Netherlands Cancer InstituteRecruitingCutaneous Squamous Cell CarcinomaNetherlands
-
Bradley A. McGregor, MDBristol-Myers Squibb; ExelixisRecruitingRenal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Unclassified Renal Cell Carcinoma | Collecting Duct Renal Cell Carcinoma | Translocation Renal Cell Carcinoma | Unresectable Advanced Renal Cell Carcinoma | Metastatic Ncc Renal Cell CarcinomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedBroad Solid TumorUnited States, Argentina, Australia, Canada, Chile, Japan, Romania, Singapore
-
Vastra Gotaland RegionBristol-Myers SquibbActive, not recruitingLiver Metastases | Uveal MelanomaSweden
-
TriSalus Life Sciences, Inc.Active, not recruitingHepatocellular Carcinoma | Intrahepatic CholangiocarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers SquibbActive, not recruitingSkin Cancer | Merkel Cell CarcinomaUnited States
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerItaly, Australia, United States, Spain, Romania, Argentina, Canada, Chile, Finland, Germany, Poland
-
Bristol-Myers SquibbTerminated
-
Dana-Farber Cancer InstituteBristol-Myers SquibbWithdrawnMelanoma Stage IV | Melanoma Stage IIIUnited States
-
Herlev HospitalActive, not recruitingPancreatic CancerDenmark
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...CompletedMetastatic Colorectal CancerItaly
-
BioNTech US Inc.Apexigen, Inc.TerminatedMetastatic MelanomaUnited States
-
Providence Health & ServicesBristol-Myers Squibb; ExelixisActive, not recruitingRefractory Cutaneous MelanomaUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
ArdigenNational Center for Research and Development, Poland; The Institute of Bioorganic...UnknownMelanoma | Healthy Volunteers | Metagenome | Immunotherapy | MicrobiomePoland
-
Shanghai Henlius BiotechRecruitingHealthy Male VolunteersChina
-
Sumitomo Pharma America, Inc.Completed
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedVarious Advanced CancerUnited States, Belgium, France, Germany, Japan, Korea, Republic of, Mexico, Netherlands, Spain, Taiwan, United Kingdom
-
Robert R. McWilliams, MDBristol-Myers Squibb; Hoosier Cancer Research NetworkActive, not recruiting
-
Bristol-Myers SquibbActive, not recruitingA Study of BMS-986253 in Combination With Nivolumab or Nivolumab Plus Ipilimumab in Advanced CancersMelanoma | CancerUnited States, Poland, Italy, Belgium, France, Australia, Canada, Germany, Spain, Sweden, Switzerland, United Kingdom